dc.contributorGonzalez-Rodriguez, Javier-Leonardo
dc.creatorCastelo Meza, Sandra Fabiola
dc.date.accessioned2020-03-26T19:21:51Z
dc.date.accessioned2022-09-22T15:02:30Z
dc.date.available2020-03-26T19:21:51Z
dc.date.available2022-09-22T15:02:30Z
dc.date.created2020-03-26T19:21:51Z
dc.identifierhttps://repository.urosario.edu.co/handle/10336/21167
dc.identifierhttps://doi.org/10.48713/10336_21167
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3444469
dc.description.abstractThis article aims to present an analysis of the situation of chronic kidney disease in Colombia related to two points to take into account, first, the market failure that initially occurred (Chicaiza, 2005) when a few Insured patients had access to dialysis, which was paid for by a package of services that did not include comprehensive care and was not always homogeneous. Second, the competitiveness of the markets around the provision of health services for kidney patients focused on developing kidney units. In other words, the service began to be offered through the same input providers, who assumed to provide the dialysis service. Competitiveness at this point was very low, since dialysis has so far no substitute products. substitute products. Therefore, those who had control of the supply of inputs also had control of the final price of that then generated a capital gap that favored the dialysis companies. Who, in turn, influenced the medical labor market. The objective of this article is, firstly, to identify the imminent kidney health problem in Colombia, secondly, to focus on the possibility of proposing public health strategies against chronic diseases by reorienting competitiveness, thirdly, raise the need for regulation of the markets around the health system as the main strategy for creating value in health to guarantee optimal patient care. Materials and Methods: The following is an account of the experience achieved in the Colombian renal clinic, which since 2004 and with the figure of an NGO, independently and without economic muscle, managed for 14 years to carry out a clinical nephrology activity. It carried out its clinical activity registry in a medical software that also generates the database of the high cost account and allows measuring non-compliance with appointments and evaluating the determining variables for risk monitoring. This Galénica software, in client server model, can be used as a single electronic record of medical history, but it could also become a computer core around which an independent, preventive medical company is developed, which redirects the objective of nephrology towards the goals of the state and towards models of economic development of the regions and the medical union. During its clinical practice, the entity obtained a sample of 1,268 patients where each had kidney function tests (BUN, creatinine), albumin, blood pressure records and anthropometric measurements were taken to identify the stage of kidney failure in Each patient according to GFR, MDRD and CKD-EPI However, it should be noted that the results in our environment with the equations do not show exactly the same results. That is, making the decision of which equation to record impacts the results differently in the age groups. Results: The highest prevalence of CKD is found in the population between 64 and 85 years of age with a peak in the prevalence between 64 and 70 years. The GFR scale showed that the highest prevalence of CKD is in stage III-B, while the MDRD scale showed a higher prevalence of stage III-A kidney disease. Finally, the CKD-EPI scale had a higher prevalence of III-A and was who had the highest prevalence of stage V kidney disease. Discussion: There is a higher prevalence in stages III-B, IV and V when using the CKD-EPI scale, which means that depending on the scale that is in force in the protocol of each institution, it will generate more or less expenses for the health system (SGSSS). The objective of the renal clinic is to design a business plan that through medical entrepreneurship allows offering a continuous strategy to primary health care (PHC), in the consolidation and deployment of the MAITE strategy of the ministry of social protection. a medical venture that allows risk management in the territories to be related through the optimization of available resources, can improve local performance in managing chronic diseases and directing cash flow towards the actions necessary for each patient to arrive at your optimum point of risk. Conclusions: The final state of chronic kidney disease is preventable, therefore instead of having a wide offer of treatment for this condition (taking into account the costs it produces for each health provider entity according to the prevalence of CKD) , it is preferable to opt for a kidney disease prevention system which can mitigate, delay or stop the progression of kidney disease to guarantee an adequate distribution of resources.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherMaestría en Administración en Salud
dc.publisherFacultad de administración
dc.rightshttp://creativecommons.org/licenses/by-sa/2.5/co/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.rightsAtribución-CompartirIgual 2.5 Colombia
dc.rightsAtribución-CompartirIgual 2.5 Colombia
dc.sourceAtkins, R. C. The epidemiology of chronic kidney disease. Kidney international (2005), 67, S14-S18.
dc.sourceCollins, A. J., Foley, R. N., Gilbertson, D. T., & Chen, S. C. (2015). United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney international supplements, 5(1), 2-7.
dc.sourceCuenta de Alto Costo. “Situación de la enfermedad renal crónica, la hipertensión arterial y la diabetes mellitus en Colombia” (2017): 58-62, 79-145.
dc.sourceDe Vecchi, Amedeo Franco, Max Dratwa, and M. E. Wiedemann. "Healthcare systems and end-stage renal disease (ESRD) therapies—an international review: costs and reimbursement/funding of ESRD therapies." Nephrology Dialysis Transplantation” (1999): 31-41.
dc.sourceFoley, R. N., Parfrey, P. S., & Sarnak, M. J. (1998). Epidemiology of cardiovascular disease in chronic renal disease. Journal of the American Society of Nephrology: JASN, 9(12 Suppl), S16-23.
dc.sourceFoley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Martin, C. J., Murray, D. C., & Barre, P. E. (1995). Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney international, 47(1), 186-192.
dc.sourceHandler, A., Issel, M., & Turnock, B. (2001). A conceptual framework to measure performance of the public health system. American Journal of Public Health, 91(8), 1235-1239.
dc.sourceHörl, W. H., De Alvaro, F., & Williams, P. F. (1999). Healthcare systems and end-stage renal disease (ESRD) therapies—an international review: access to ESRD treatments. Nephrology Dialysis Transplantation, 14(suppl_6), 10-15.
dc.sourceLee, H., Manns, B., Taub, K., Ghali, W. A., Dean, S., Johnson, D., & Donaldson, C. (2002). Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. American Journal of Kidney Diseases, 40(3), 611-622.
dc.sourceLo, L. J., Go, A. S., Chertow, G. M., McCulloch, C. E., Fan, D., Ordoñez, J. D., & Hsu, C. Y. (2009). Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney international, 76(8), 893-899.
dc.sourceLopera-Medina, Mónica María. "La enfermedad renal crónica en Colombia: necesidades en salud y respuesta del Sistema General de Seguridad Social en Salud." Revista Gerencia y Políticas de salud 15.30 (2016): 212-233.
dc.sourceMehrotra, R., Chiu, Y. W., Kalantar-Zadeh, K., Bargman, J., & Vonesh, E. (2011). Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Archives of internal medicine, 171(2), 110-118.
dc.sourceModelo TreeAge. “Decisiones de costo efectividad” (1999).
dc.sourcede Moura, L., Prestes, I. V., Duncan, B. B., Thome, F. S., & Schmidt, M. I. (2014). Dialysis for end stage renal disease financed through the Brazilian National Health System, 2000 to 2012. BMC nephrology, 15(1), 111.
dc.sourceMurtagh, Fliss EM, Julia Addington-Hall, and Irene J. Higginson. "The prevalence of symptoms in end-stage renal disease: a systematic review." Advances in chronic kidney disease 14.1 (2007): 82-99.
dc.sourceNational Kidney and Urologic Diseases Information Clearinghouse (NKUDIC). Kidney Disease Statistics for the United States. US Department of Health and Human Services. Disponible en: http://kidney.niddk.nih.gov/kudiseases/pubs/kustats/#7. Accedido: 27 Septiembre 2019
dc.sourceSaran, R., Robinson, B., Abbott, K. C., Agodoa, L. Y., Bhave, N., Bragg-Gresham, J., ... & Gaipov, A. (2018). US renal data system 2017 annual data report: epidemiology of kidney disease in the United States. American journal of kidney diseases: the official journal of the National Kidney Foundation, 71(3 Suppl 1), A7.
dc.sourceParra Moncasi, E., Jiménez, A., Alonso, M., Martínez, M. F., Gámen Pardo, A., Rebollo, P., & Álvarez-Ude, F. (2011). Estudio multicéntrico de costes en hemodiálisis. Nefrología (Madrid), 31(3), 299-307.
dc.sourceSecretaria Distrital de Salud. “Documento de Análisis de Situación de Salud con el Modelo de los Determinantes Sociales de Salud para el Distrito Capital” (2019): 141-155.
dc.sourceTangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS. A predictive model for progression of chronic kidney disease to kidney failure. Jama. 2011 Apr 20;305(15):1553-9.
dc.sourceHsu CY, Ordonez JD, Chertow GM, Fan D, McCulloch CE, Go AS. The risk of acute renal failure in patients with chronic kidney disease. Kidney international. 2008 Jul 1;74(1):101-7.
dc.sourceLevey AS, Coresh J, Bolton K, Culleton B, Harvey KS, Ikizler TA, Johnson CA, Kausz A, Kimmel PL, Kusek J, Levin A. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases. 2002 Mar 9;39(2 SUPPL. 1).
dc.sourceTonkin-Crine S, Okamoto I, Leydon GM, Murtagh FE, Farrington K, Caskey F, Rayner H, Roderick P. Understanding by older patients of dialysis and conservative management for chronic kidney failure. American Journal of Kidney Diseases. 2015 Mar 1;65(3):443-50.
dc.sourceMenon V, Wang X, Sarnak MJ, Hunsicker LH, Madero M, Beck GJ, Collins AJ, Kusek JW, Levey AS, Greene T. Long-term outcomes in nondiabetic chronic kidney disease. Kidney international. 2008 Jun 1;73(11):1310-5.
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectEnfermedad Renal Cronica
dc.subjectDiálisis
dc.subjectCostos en salud
dc.subjectEmprendimiento Medico
dc.subjectGerencia de riesgos
dc.titleDiseño de una red de servicios para la prevención y atención de la enfermedad renal crónica: un planteamiento y propuesta de un caso de emprendimiento medico.
dc.typemasterThesis


Este ítem pertenece a la siguiente institución